This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Northcott, C. Articles by Watts, S. W. Search for Related Content PubMed PubMed Citation Articles by Northcott, C. Articles by Watts, S. W. Related Collections Cell signalling/signal transduction Growth factors/cytokines Hypertension - basic studies Receptor pharmacology

(Hypertension. 2001;38:1337.)
© 2001 American Heart Association, Inc.

Scientific Contributions

Arterial Epidermal Growth Factor Receptor Expression in Deoxycorticosterone Acetate–Salt Hypertension

Carrie Northcott; Jennifer A. Florian; Anne Dorrance; Stephanie W. Watts

From the Department of Pharmacology and Toxicology, Michigan State University (C.N., J.F., S.W.), East Lansing; and Department of Physiology, Medical College of Georgia (A.D.), Augusta.

Correspondence to Stephanie W. Watts, B445 Life Sciences Bldg, Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824-1317. E-mail wattss{at}msu.edu

Epidermal growth factor (EGF) causes contraction in arteries from deoxycorticosterone acetate (DOCA)–salt hypertensive rats but not in normotensive sham rats. We hypothesized that an increase in the number of EGF receptors (EGFRs) in arteries from DOCA-salt rats enables the observed contraction to EGF to occur. DOCA-salt rats had a systolic blood pressure >170 mm Hg, whereas all sham rats had a systolic blood pressure <125 mm Hg. Thoracic aorta were removed for measurement of isometric force, EGFR mRNA levels, and EGFR protein levels. EGF caused a significant contraction in endothelium-denuded aorta from DOCA-salt rats (38±7% of maximal phenylephrine-induced [10 µmol/L] contraction) compared with aorta from sham rats (4±2%). The EGFR tyrosine kinase–specific inhibitors 4,5-dianilinophthalimide (10 µmol/L) and AG1478 (250 nmol/L) reduced contraction in aorta from DOCA-salt by 85±14% and 65±10%, respectively. EGFR mRNA in DOCA-salt aorta was increased 4.2-fold compared with that in sham aorta. However, Western analyses of membrane-enriched and whole-tissue lysate of aorta from sham and DOCA-salt revealed no statistical difference in the density of EGFR protein between sham and DOCA-salt aorta. These data refute our hypothesis and suggest that a change downstream of EGFR is responsible for enabling EGF-induced contraction in hypertension.

Key Words: EGF • mineralocorticoid • artery • tyrosine kinase

This article has been cited by other articles:

				F. Helle, C. Jouzel, C. Chadjichristos, S. Placier, M. Flamant, D. Guerrot, H. Francois, J.-C. Dussaule, and C. Chatziantoniou Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism Am J Physiol Renal Physiol, July 1, 2009; 297(1): F191 - F199. [Abstract] [Full Text] [PDF]

				C. Grossmann, A. W. Krug, R. Freudinger, S. Mildenberger, K. Voelker, and M. Gekle Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1790 - E1800. [Abstract] [Full Text] [PDF]

				R. W. Carter and N. L. Kanagy Tyrosine kinases regulate intracellular calcium during alpha 2-adrenergic contraction in rat aorta Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1673 - H1680. [Abstract] [Full Text] [PDF]